![PDF) Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias PDF) Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias](https://i1.rgstatic.net/publication/40045065_Tailoring_iron_chelation_by_iron_intake_and_serum_ferritin_The_prospective_EPIC_study_of_deferasirox_in_1744_patients_with_transfusion-dependent_anemias/links/0deec52099a9e36e42000000/largepreview.png)
PDF) Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias
![PDF) Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study | J. Troncy - Academia.edu PDF) Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study | J. Troncy - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/51012077/mini_magick20190126-27476-135qovv.png?1548555101)
PDF) Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study | J. Troncy - Academia.edu
![P.C. RICCI | Professor (Associate) | Ph.D. | Università degli studi di Cagliari, Cagliari | UNICA | Department of Physics P.C. RICCI | Professor (Associate) | Ph.D. | Università degli studi di Cagliari, Cagliari | UNICA | Department of Physics](https://www.researchgate.net/profile/Pc-Ricci/publication/364555914/figure/fig1/AS:11431281092235320@1666771774656/Strategies-to-enhance-the-photocatalytic-activity_Q320.jpg)
P.C. RICCI | Professor (Associate) | Ph.D. | Università degli studi di Cagliari, Cagliari | UNICA | Department of Physics
![PDF) Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic Melanoma PDF) Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic Melanoma](https://i1.rgstatic.net/publication/340566761_Population_PharmacokineticsPharmacodynamics_of_Dabrafenib_Plus_Trametinib_in_Patients_with_BRAF-Mutated_Metastatic_Melanoma/links/5e90f17992851c2f5294b61f/largepreview.png)
PDF) Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic Melanoma
![PDF) The International Hemoglobinopathy Research Network (INHERENT): An International Initiative to Study the Role of Genetic Modifiers in Hemoglobinopathies PDF) The International Hemoglobinopathy Research Network (INHERENT): An International Initiative to Study the Role of Genetic Modifiers in Hemoglobinopathies](https://i1.rgstatic.net/publication/356490469_The_International_Hemoglobinopathy_Research_Network_INHERENT_An_International_Initiative_to_Study_the_Role_of_Genetic_Modifiers_in_Hemoglobinopathies/links/62164e9e791f4437f158c903/largepreview.png)
PDF) The International Hemoglobinopathy Research Network (INHERENT): An International Initiative to Study the Role of Genetic Modifiers in Hemoglobinopathies
![Franco LOCATELLI | Ospedale Pediatrico Bambino Gesù, Rome | Bambino Gesù | Department of Pediatric Onco-Hematology and Transfusion Medicine Franco LOCATELLI | Ospedale Pediatrico Bambino Gesù, Rome | Bambino Gesù | Department of Pediatric Onco-Hematology and Transfusion Medicine](https://www.researchgate.net/publication/325739432/figure/fig2/AS:958790824390660@1605604954318/Overall-survival-of-patients-transplanted-for-extramedullary-relapse-of-ALL_Q320.jpg)